Screening for Prognostic Biomarkers in Metastatic Adrenocortical Carcinoma by Tissue Micro Arrays Analysis Identifies P53 as an Independent Prognostic Marker of Overall Survival

Simple Summary The aim of our retrospective study was to identify and prioritize potential prognostic parameters in a well characterized metastatic ACC population. We identified for the first time P53 as an independent prognostic marker of metastatic adrenocortical carcinoma after mENSAT-GRAS parameter adjustment. This biomarker is easily available and should be considered in clinical practice together with Ki67 for the management of patient with advanced ACC. Moreover, this study underlies the importance of adjustment of potential biomarkers to validated prognostic factors in order to avoid the accumulation of invalidated biomarkers not usable in clinical practice. Advanced adrenocortical carcinoma (ACC) has poor but heterogeneous prognosis. Apart from Ki67 index, no prognostic or predictive biomarker has been validated in advanced ACC, so far. We aimed at analyzing expression of a large panel of proteins involved in known altered pathways in ACC (cell cycle, Wnt/ss-catenin, methylation) to identify and prioritize potential prognostic or predictive parameters metastatic ACC population. We conducted a retrospective multicentric study. Overall survival (OS) and partial response according to RECIST 1.1 were primary endpoints. TMA was set up and 16 markers were analyzed. Modified ENSAT and GRAS parameters were characterized for prognostic adjustment. Results: We included 66 patients with a mean age at metastatic diagnosis of 48.7 +/- 15.5 years. Median survival was 27.8 months. After adjustment to mENSAT-GRAS parameters, p53 and PDxK were prognostic of OS. No potential biomarker has been identified as predictive factor of response. We identified for the first time P53 as an independent prognostic marker of metastatic adrenocortical carcinoma after mENSAT-GRAS parameter adjustment. Prognostic impact of Wnt/ss-catenin alterations was not confirmed in this cohort of metastatic ACC.

Automated summary

The aim of this study was to identify and prioritize potential prognostic parameters in metastatic ACC. The study found P53 and PDxK to be independent prognostic markers of metastatic adrenocortical carcinoma, highlighting the importance of adjusting biomarkers to validated prognostic factors.